Last reviewed · How we verify
NCT05934721
Relationship Between Rheumatoid Arthritis Severity and Cognition in the Elderly: The Role of Nociplastic Pain
trial testing Questionnaire and physical assessments in Rheumatoid Arthritis in 100 participants. Status unknown.
31 December 2023
Quick facts
| Lead sponsor | Ahram Canadian University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 100 |
| Start date | 15 July 2023 |
| Primary completion | 31 December 2023 |
| Estimated completion | 31 December 2023 |
| Sites | 1 location across Egypt |
Drugs / interventions tested
- Questionnaire and physical assessments
Conditions studied
- Rheumatoid Arthritis — all drugs for Rheumatoid Arthritis →
- Rheumatic Diseases — all drugs for Rheumatic Diseases →
- Rheumatoid Polyarthritis — all drugs for Rheumatoid Polyarthritis →
Sponsor
Ahram Canadian University
Who can join
Adults 65 to 90, any sex, with Rheumatoid Arthritis or Rheumatic Diseases. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
this study aims to determine if nociplastic pain mediates the relationship between rheumatoid arthritis (RA) severity and cognitive impairment in geriatric patients 100 patients aged 65-90 years with long-standing RA and assess their disease severity, cognition, and pain sensitization will be recruited. Expectations that patients with more severe RA will have worse cognitive function, and that this relationship will be mediated by higher levels of nociplastic pain.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT05934721
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Rheumatoid Arthritis
Currently open trials in the same condition.
- NCT07433335 — A Study to Assess the Safety and Tolerability of SR-878 in Patients With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07491016 — Efficacy and Safety of Telitacicept Combined With Baricitinib for Refractory Rheumatoid Arthritis · recruiting
- NCT07171983 — A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986454 in Participants With Rheumatoid Arthritis · Phase 1 · recruiting
- NCT07246096 — Exploratory Clinical Study on the Safety and Efficacy of Anti- CD19/BCMA U CAR-T Cell Injection for the Treatment of Rel · EARLY_PHASE1 · recruiting
- NCT07363590 — A Clinical Study of MK-1045 in People With Lupus or Rheumatoid Arthritis (MK-1045-004) · Phase 1 · recruiting
Other Ahram Canadian University trials
Trials by the same sponsor.
- NCT07305610 — INFLUENCE OF SELECTED POSITIONS ON HIP ABDUCTORS STRENGTH AND ACTIVATION IN PATELLOFEMORAL PAIN SYNDROME IN MALES · not yet recruiting
- NCT07102992 — Post Burn Cubital Tunnel Syndrome Response to High Intensity Laser Therapy Versus Shock Wave Therapy · NA · completed
- NCT07103109 — Impact of Proximal Motor Control Exercise on Scapular Muscles Activation Pattern Post Mastectomy · NA · recruiting
- NCT06978426 — Hand-Held Dynamometer Assessment: E-Sports Grip-Asymmetry Index as a Predictor of Wrist Pain · recruiting
- NCT06508190 — Free Walking Exercise in Obstructive Sleep Apnea Patients With Non-alcoholic Fatty Liver · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT05934721 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Ahram Canadian University
- Last refreshed: 7 July 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT05934721.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing